Viracta Therapeutics
Why Robinhood?
You can watch VIRX and buy or sell other stocks, ETFs, and their options commission-free!About VIRX
Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas.
VIRX Key Statistics
Stock Snapshot
Viracta Therapeutics(VIRX) stock is priced at $0.01, giving the company a market capitalization of 388.7K. It carries a P/E multiple of -0.01.
Viracta Therapeutics(VIRX) stock opened on 2026-10-28 at —. The price climbed to — and dipped to —.
The Viracta Therapeutics(VIRX)'s current trading volume is 0, compared to an average daily volume of 491.85K.
In the last year, Viracta Therapeutics(VIRX) shares hit a 52-week high of $0.58 and a 52-week low of $0.01.
In the last year, Viracta Therapeutics(VIRX) shares hit a 52-week high of $0.58 and a 52-week low of $0.01.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.